Latest filing published 26 Aug 2026 for GoodRx Holdings, Inc., €1.3M. Read the official filing
Francisco Partners IV, L.P. discloses dealings in GoodRx Holdings, Inc. to SEC (Form 4). The record holds 20 filings, for trades running from 6 March 2024 to 26 August 2026.
The open-market record consists of 14 sales worth €8.3M, with no purchase. Since January 2026: no purchases and 14 sales on the market.
Most recently, on 26 August 2026, the filings show an open-market sale worth €1.3M in GoodRx Holdings, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations